Kronos Bio, Inc.
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks th…
Biotechnology
US, San Mateo [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Kronos Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDKronos Bio, Inc. can't present revenue by segment